All Stories

  1. Evolving the Understanding of Quantifying Tricuspid Regurgitation: From Doppler Assumptions to Volumetric Accuracy
  2. Quantitative tricuspid regurgitation assessment by cardiac magnetic resonance: novel insights
  3. Comparison of dual-energy iodine and standard subtraction methods for myocardial extracellular volume quantification using cardiac computed tomography
  4. Key takeaways from the 2025 expert consensus document on cardiac computed tomography for prosthetic heart valve assessment
  5. Coronary Computed Tomography Angiography to Guide Percutaneous Coronary Intervention: Expert Opinion from a SCAI/SCCT Roundtable
  6. Sex differences in pre- and post-surgical left ventricular remodelling and outcomes in primary mitral regurgitation
  7. Development and Validation of Imaging‐Free Myocardial Fibrosis Prediction Models, Association with Outcomes, and Sample Size Estimation for Phase 3 Trials
  8. 3D Echocardiographic and CMR Imaging for the Assessment of Right Ventricular Function and Tricuspid Regurgitation Severity
  9. Understanding Right Heart Flow: Implications for Interatrial Shunt Device Therapy in Heart Failure
  10. Acute Myocarditis as the Initial Presentation of Desmoplakin Mutation – Broadening the Differential Diagnosis
  11. Miocardite Aguda como Apresentação Inicial da Mutação da Desmoplaquina – Ampliando o Diagnóstico Diferencial
  12. Arrhythmic mitral valve prolapse and mitral annular disjunction: pathophysiology, risk stratification, and management
  13. Rasamsonia argillacea species complex myocarditis in a patient with chronic granulomatous disease
  14. Right Ventricular Function and Prognosis in Patients with Low-Flow, Low-Gradient Severe Aortic Stenosis
  15. A pathoanatomic approach to the management of mitral regurgitation
  16. Diastolic function improvement is associated with favourable outcomes in patients with acute non-ischaemic cardiomyopathy: insights from the multicentre IMAC-2 trial
  17. Watchful waiting in aortic stenosis: are we ready for individualizing the risk assessment?
  18. TCT-662 Prognostic Importance Of Pulmonary Hypertension Etiology By Invasive Hemodynamics In Patients With Severe Aortic Stenosis
  19. Acute cocaine myocarditis: a word of caution
  20. The association of global longitudinal and global circumferential strain with ejection fraction in patients with aortic stenosis and increased left ventricular mass: a feature tracking CMR study
  21. Meta-analysis of coronary computed tomography angiography versus standard of care strategy for the evaluation of low risk chest pain: Are randomized controlled trials and cohort studies showing the same evidence?
  22. Is there a role for diastolic function assessment in era of delayed enhancement cardiac magnetic resonance imaging?
  23. HEMODYNAMIC ASSESSMENT OF LOW GRADIENT AORTIC STENOSIS WITH PRESERVED EJECTION FRACTION
  24. Global left ventricular remodeling, extent of inferior wall infarct, and mitral valve geometry are important predictors of mitral regurgitation severity than total infarct size in advanced ischemic cardiomyopathy
  25. From Headache to Heartache
  26. Feature tracking measurement of dyssynchrony from cardiovascular magnetic resonance cine acquisitions: comparison with echocardiographic speckle tracking
  27. Role of Cross-Sectional Imaging for Structural Heart Disease Interventions
  28. An Unexpected Fate
  29. BARIATRIC SURGERY IS ASSOCIATED WITH LEFT VENTRICULAR EJECTION FRACTION IMPROVEMENT IN OBESE PATIENTS WITH SYSTOLIC HEART FAILURE
  30. IMPACT OF MITRAL REGURGITATION ON MORTALITY IN PATIENTS WITH SEVERE ISCHEMIC CARDIOMYOPATHY AND SUBSEQUENT INCOMPLETE REVASCULARIZATION IN THE SETTING OF JEOPARDIZED MYOCARDIUM
  31. Two-Dimensional Longitudinal Strain Assessment in the Presence of Myocardial Contrast Agents Is Only Feasible with Speckle-Tracking after Microbubble Destruction
  32. Association of Epicardial Fat, Hypertension, Subclinical Coronary Artery Disease, and Metabolic Syndrome With Left Ventricular Diastolic Dysfunction
  33. Role of Echocardiography in Percutaneous Mitral Valve Interventions
  34. Diversity of Mitral Valve Abnormalities in Obstructive Hypertrophic Cardiomyopathy
  35. A New Diagnosis of Severe Aortic Coarctation Presenting in Adult Life
  36. Regadenoson is a safe and well-tolerated pharmacological stress agent for myocardial perfusion imaging in post-heart transplant patients
  37. Aortic Stiffness
  38. REGIONAL LV AND RV FREE WALL LONGITUDINAL STRAIN BY SPECKLE TRACKING IS REDUCED IN PATIENTS WITH CONSTRICTIVE PERICARDITIS: AN MRI CORRELATION STUDY
  39. Assessing Risk and Predicting Outcomes in Coronary Artery Disease: Physiology, Anatomy, or Biology?
  40. Role of multimodality imaging in ischemic and non-ischemic cardiomyopathy
  41. Isolated Right Ventricular Infarct Presenting as Ventricular Fibrillation Arrest and Confirmed by Delayed-Enhancement Cardiac MRI
  42. VALUE OF FAMILY HISTORY OF PREMATURE CORONARY ARTERY DISEASE AS A PREDICTOR OF OBSTRUCTIVE CORONARY ARTERY DISEASE ON CORONARY CT ANGIOGRAPHY, THE ACIC REGISTRY
  43. IS STRESS MYOCARDIAL PERFUSION IMAGING WITH REGADENOSON, A NEW PHARMACOLOGIC STRESS AGENT, SAFE IN ORTHOTOPIC HEART TRANSPLANT PATIENTS? FIRST REPORT OF REGADENOSON, A SELECTIVE A2A RECEPTOR AGONIST IN THE HEART TRANSPLANT POPULATION
  44. EVEREST study: Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan
  45. The Relationship Between Spontaneous Echocontrast, Transesophageal Echocardiographic Parameters, and Blood Hemoglobin Levels
  46. Renal Response After High-Dose Melphalan and Stem Cell Transplantation Is a Favorable Marker in Patients With Primary Systemic Amyloidosis
  47. Effects of l-arginine-enriched total enteral nutrition on body weight gain, tumor growth, and in vivo concentrations of blood and tissue metabolites in rats inoculated with Walker tumor in the kidney
  48. Modelo de tumor experimental em rim de ratos